n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with dapi in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beneytout, JL; Le Bail, JC; Liagre, B; Moalic, S | 1 |
| Hwang, SY; Kim, JC; Kim, JO; Kim, MK; Kwack, MH; Park, MK; Sung, YK | 1 |
| Cummins, J; Huard, J; Li, Y; Shen, W; Tang, Y | 1 |
3 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and dapi
| Article | Year |
|---|---|
Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Topics: Adenovirus E1A Proteins; Apoptosis; Arachidonic Acid; bcl-2-Associated X Protein; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Dose-Response Relationship, Drug; Humans; Indoles; Isoenzymes; Membrane Proteins; Nitrobenzenes; Osteosarcoma; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Cells, Cultured | 2001 |
NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Immunoblotting; Indoles; Liver Neoplasms; Nitrobenzenes; Sulfonamides; Time Factors | 2004 |
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Cell Extracts; Cell Proliferation; Cells, Cultured; Collagen; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Flow Cytometry; Fluorescein; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Immunohistochemistry; Indoles; Kinetics; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Models, Anatomic; Muscle, Skeletal; Myostatin; Nitrobenzenes; Regeneration; Staining and Labeling; Stem Cells; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2005 |